Imvax
Personalized whole tumor-derived immunotherapy vaccines
- Sector
- Biotech
- Headquarters
- PHILADELPHIA, PA
- Founded
- 2015
- Latest Form D
- $112M, Jul 2020
- Total capital
- $152M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $152M
- 3 Form D · last Jul 2020
- 75 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$112M
- Private capital raisedForm D · SEC · 2nd filing$24.8M
- Private capital raisedForm D · SEC · 1st filing$14.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Arthur W HoweExecutive Officer, DirectorNamed in SEC Form D filings
- David AndrewsExecutive Officer, DirectorNamed in SEC Form D filings
- David W BunningDirectorNamed in SEC Form D filings
- Ira W BrindDirectorNamed in SEC Form D filings
- John W FureyExecutive Officer, DirectorNamed in SEC Form D filings
- Peter W CorrDirectorNamed in SEC Form D filings
Show all 10 people
- Steven W AltschulerDirectorNamed in SEC Form D filings
- Ted W KoutouzisDirectorNamed in SEC Form D filings
- Thomas W PfistererDirectorNamed in SEC Form D filings
- Wendy W DiCiccoDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingApparatus And Methods For Biodiffusion Chamber StorageUSPTOApplication 17761123
- PendingMethods And Composition For Inhibiting Tumor Growth And Enhancing Immune Responses To TumorsUSPTOApplication 16487612
- PendingApparatus And Methods For Biodiffusion Chamber StorageUSPTOApplication 62902551
Show all 8 patent records
- Apparatus And Methods For Biodiffusion Chamber StorageNov 24, 2022 · Application 17761123Pending
- Methods And Composition For Inhibiting Tumor Growth And Enhancing Immune Responses To TumorsFeb 20, 2020 · Application 16487612Pending
- Apparatus And Methods For Biodiffusion Chamber StorageApplication 62902551Pending
- Biodiffusion ChamberApplication PCTUS2019014961Pending
- Biodiffusion ChamberApplication 62621295Pending
- Methods And Compositions For Treating Bladder CancerApplication 63378437Pending
- Methods And Compositions For Treating Cancers Using AntisenseApplication 62469003Pending
- Apparatus And Methods For Biodiffusion Chamber StorageApplication PCTUS2020051376Pending
Related companies, and why
- Galecto, Inc.Similar federal contract value in Biotech · null in contracts
- Allogene TherapeuticsSimilar federal contract value in Biotech · null in contracts
- RayzeBioSimilar federal contract value in Biotech · null in contracts
- Zenas BioPharmaSimilar federal contract value in Biotech · null in contracts
- ProEncia Biotechnology Inc.Similar federal contract value in Biotech · null in contracts
- Metagenomi Technologies, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .